Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SBGneuro is a private UK-based neuroimaging services company that provides MRI and fMRI acquisition support, quality control, analysis, and interpretation for clinical trials. The company focuses on using structural and functional MRI as non-invasive biomarkers across neurological and neuropsychiatric disease research. Its offerings include pre-trial consulting, study design and acquisition optimization, endpoint definition, data quality control, integrated imaging analysis, and post-trial interpretation. SBGneuro appears to operate as a specialist imaging analytics and biomarker partner for pharma, biotech, and CRO-sponsored studies rather than as a therapeutic drug developer. The company also participates in collaborative research projects such as PRISM 2.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SBGneuro.